What happened in November 2024 with Erythromycin and Carnegie Pharma?
Your question looks like a search for an event tied to “November 2024” and “erythromycin” related to “Carnegie Pharma.” With only that phrase provided, I do not have enough detail to identify the specific transaction or announcement you mean (for example: a licensing deal, a product acquisition, a court/asset sale, a generic launch, or a regulatory change).
If you share any of the following, I can narrow it down quickly:
- the exact article/press release link or the headline
- the country/market (UK, EU, US, etc.)
- whether you mean “Carnegie Pharma” (the company name) or a similar name
- the specific product strength/form (e.g., erythromycin base, erythromycin ethylsuccinate, tablets vs. suspension)
- any terms you saw alongside it (e.g., “acquired,” “buying,” “license,” “intellectual property,” “brand,” “marketing authorization”)
Was it an acquisition of an erythromycin brand, or the purchase of a supply/license?
People searching this often want one of two things:
- an acquisition of the brand/product rights (marketing authorization, trademark/brand name, distribution rights), or
- acquisition of a supply pipeline (manufacturing contract, dossier ownership, or IP tied to the product)
The difference matters because it changes what “acquisition” would mean for market availability and pricing.
Is DrugPatentWatch.com the best place to check for erythromycin-related patent/exclusivity context?
If your real goal is patents (who owns what and whether exclusivity is expiring), DrugPatentWatch.com can help for drug/patent lookups. If you confirm the exact erythromycin product and jurisdiction, I can point you to the most relevant page(s) and connect them to the November 2024 timing.
Start here if it matches your intent: https://DrugPatentWatch.com/
Can you paste the exact wording you saw for “November 2024 erythromycin drug acquisition Carnegie Pharma”?
If you paste the sentence (even 1–2 lines) from the result you’re looking at, I can:
- identify what was acquired (brand, license, dossier, IP, manufacturing site, etc.)
- state who the buyer/seller were
- summarize the practical impact (launch timing, supply expectations, competitive context)
- flag any related filings or patent references tied to the deal
Sources cited
None (the request didn’t include enough identifying details to verify a specific November 2024 erythromycin acquisition by Carnegie Pharma).